The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Inhibition of HIV Fusion with Multivalent Gold Nanoparticles
Open accessAbstract
The design and synthesis of a multivalent gold nanoparticle therapeutic is presented. SDC-1721, a fragment of the potent HIV inhibitor TAK-779, was synthesized and conjugated to 2.0 nm diameter gold nanoparticles. Free SDC-1721 had no inhibitory effect on HIV infection; however, the (SDC-1721)-gold nanoparticle conjugates displayed activity comparable to that of TAK-779. This result suggests that multivalent presentation of small molecules on gold nanoparticle surfaces can convert inactive drugs into potent therapeutics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mammen, M., Choi, S.-K., & Whitesides, G. M. (1998) · Angewandte Chemie International Edition · doi:10.1002/(sici)1521-3773(19981102)37:20<2754::aid-anie2754>3.0.co;2-3 · Cited by 4,110
Structure of a Thiol Monolayer-Protected Gold Nanoparticle at 1.1 Å Resolution
Jadzinsky, P. D., Calero, G., Ackerson, C. J., Bushnell, D. A., & Kornberg, R. D. (2007) · Science · doi:10.1126/science.1148624 · Cited by 2,654
Self-citationAntibody neutralization and escape by HIV-1
Wei, X., Decker, J. M., Wang, S., Hui, H., Kappes, J. C., Wu, X., Salazar-Gonzalez, J. F., Salazar, M. G., Kilby, J. M., Saag, M. S., et al. (2003) · Nature · doi:10.1038/nature01470 · Cited by 2,421
Wei, X., Decker, J. M., Liu, H., Zhang, Z., Arani, R. B., Kilby, J. M., Saag, M. S., Wu, X., Shaw, G. M., & Kappes, J. C. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.1896-1905.2002 · Cited by 1,569
A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity
Baba, M., Nishimura, O., Kanzaki, N., Okamoto, M., Sawada, H., Iizawa, Y., Shiraishi, M., Aramaki, Y., Okonogi, K., Ogawa, Y., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5698 · Cited by 751
Moore, J. P., Kitchen, S. G., Pugach, P., & Zack, J. A. (2004) · AIDS Research and Human Retroviruses · doi:10.1089/088922204322749567 · Cited by 494
Nanotechnological applications in medicine
Caruthers, S. D., Wickline, S. A., & Lanza, G. M. (2007) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2007.01.006 · Cited by 441
Reeves, J. D., Gallo, S. A., Ahmad, N., Miamidian, J. L., Harvey, P. E., Sharron, M., Pöhlmann, S., Sfakianos, J. N., Derdeyn, C. A., Blumenthal, R., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.252469399 · Cited by 404
Lytton-Jean, A. K. R., & Mirkin, C. A. (2005) · Journal of the American Chemical Society · doi:10.1021/ja052255o · Cited by 308
Barbaro, G., Scozzafava, A., Mastrolorenzo, A., & Supuran, C. (2005) · Current Pharmaceutical Design · doi:10.2174/1381612053764869 · Cited by 222
Cited by
Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity
Boisselier, E., & Astruc, D. (2009) · Chemical Society Reviews · doi:10.1039/b806051g · Cited by 2,842
Gold Nanoparticles for Biology and Medicine
Giljohann, D. A., Seferos, D. S., Daniel, W. L., Massich, M. D., Patel, P. C., & Mirkin, C. A. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.200904359 · Cited by 2,356
Gold nanoparticles in biomedical applications: recent advances and perspectives
Dykman, L., & Khlebtsov, N. (2012) · Chem. Soc. Rev. · doi:10.1039/c1cs15166e · Cited by 1,961
The gold–sulfur interface at the nanoscale
Häkkinen, H. (2012) · Nature Chemistry · doi:10.1038/nchem.1352 · Cited by 1,727
Intrinsic therapeutic applications of noble metal nanoparticles: past, present and future
Arvizo, R. R., Bhattacharyya, S., Kudgus, R. A., Giri, K., Bhattacharya, R., & Mukherjee, P. (2012) · Chemical Society Reviews · doi:10.1039/c2cs15355f · Cited by 866
Zhao, Y., Tian, Y., Cui, Y., Liu, W., Ma, W., & Jiang, X. (2010) · Journal of the American Chemical Society · doi:10.1021/ja1028843 · Cited by 592
Gold Nanoparticles for Nucleic Acid Delivery
Ding, Y., Jiang, Z., Saha, K., Kim, C. S., Kim, S. T., Landis, R. F., & Rotello, V. M. (2014) · Molecular Therapy · doi:10.1038/mt.2014.30 · Cited by 521
Mechanisms of drug release in nanotherapeutic delivery systems
Wong, P. T., & Choi, S. K. (2015) · Chemical Reviews · doi:10.1021/cr5004634 · Cited by 507
Gold compounds as therapeutic agents for human diseases
Berners-Price, S. J., & Filipovska, A. (2011) · Metallomics · doi:10.1039/c1mt00062d · Cited by 495
Current applications and future perspective of CRISPR/Cas9 gene editing in cancer
Wang, S.-W., Gao, C., Zheng, Y.-M., Yi, L., Lu, J.-C., Huang, X.-Y., Cai, J.-B., Zhang, P.-F., Cui, Y.-H., & Ke, A.-W. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01518-8 · Cited by 478
More Effective Nanomedicines through Particle Design
Wang, J., Byrne, J. D., Napier, M. E., & DeSimone, J. M. (2011) · Small · doi:10.1002/smll.201100442 · Cited by 466
Broad-spectrum non-toxic antiviral nanoparticles with a virucidal inhibition mechanism
Cagno, V., Andreozzi, P., D’Alicarnasso, M., Jacob Silva, P., Mueller, M., Galloux, M., Le Goffic, R., Jones, S. T., Vallino, M., Hodek, J., et al. (2018) · Nature Materials · doi:10.1038/nmat5053 · Cited by 428
Topical delivery of siRNA-based spherical nucleic acid nanoparticle conjugates for gene regulation
Zheng, D., Giljohann, D. A., Chen, D. L., Massich, M. D., Wang, X.-Q., Iordanov, H., Mirkin, C. A., & Paller, A. S. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1118425109 · Cited by 409
Khezerlou, A., Alizadeh-Sani, M., Azizi-Lalabadi, M., & Ehsani, A. (2018) · Microbial Pathogenesis · doi:10.1016/j.micpath.2018.08.008 · Cited by 404
A repertoire of biomedical applications of noble metal nanoparticles
Azharuddin, M., Zhu, G. H., Das, D., Ozgur, E., Uzun, L., Turner, A. P. F., & Patra, H. K. (2019) · Chemical Communications · doi:10.1039/c9cc01741k · Cited by 395
Evidence for Biomagnification of Gold Nanoparticles within a Terrestrial Food Chain
Judy, J. D., Unrine, J. M., & Bertsch, P. M. (2011) · Environmental Science & Technology · doi:10.1021/es103031a · Cited by 376
Baram-Pinto, D., Shukla, S., Perkas, N., Gedanken, A., & Sarid, R. (2009) · Bioconjugate Chemistry · doi:10.1021/bc900215b · Cited by 368
The role of nanotechnology in the treatment of viral infections
Singh, L., Kruger, H. G., Maguire, G. E. M., Govender, T., & Parboosing, R. (2017) · Therapeutic Advances in Infectious Disease · doi:10.1177/2049936117713593 · Cited by 360
Wang, J., Tian, S., Petros, R. A., Napier, M. E., & DeSimone, J. M. (2010) · Journal of the American Chemical Society · doi:10.1021/ja1043177 · Cited by 330
Inhibition of Influenza Virus Infection by Multivalent Sialic‐Acid‐Functionalized Gold Nanoparticles
Papp, I., Sieben, C., Ludwig, K., Roskamp, M., Böttcher, C., Schlecht, S., Herrmann, A., & Haag, R. (2010) · Small · doi:10.1002/smll.201001349 · Cited by 313
Gold, Silver, and Palladium Nanoparticles: A Chemical Tool for Biomedical Applications
Yaqoob, S. B., Adnan, R., Rameez Khan, R. M., & Rashid, M. (2020) · Frontiers in Chemistry · doi:10.3389/fchem.2020.00376 · Cited by 308
Burlec, A. F., Corciova, A., Boev, M., Batir-Marin, D., Mircea, C., Cioanca, O., Danila, G., Danila, M., Bucur, A. F., & Hancianu, M. (2023) · Pharmaceuticals · doi:10.3390/ph16101410 · Cited by 295
Strategic role of selected noble metal nanoparticles in medicine
Rai, M., Ingle, A. P., Birla, S., Yadav, A., & Santos, C. A. D. (2015) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2015.1018131 · Cited by 290
Metal-Based Nanoparticles for the Treatment of Infectious Diseases
Aderibigbe, B. (2017) · Molecules · doi:10.3390/molecules22081370 · Cited by 269
Emerging Nanotechnology Approaches for HIV/AIDS Treatment and Prevention
Mamo, T., Moseman, E. A., Kolishetti, N., Salvador-Morales, C., Shi, J., Kuritzkes, D. R., Langer, R., Andrian, U. V., & Farokhzad, O. C. (2010) · Nanomedicine · doi:10.2217/nnm.10.1 · Cited by 255
An overview of functional nanoparticles as novel emerging antiviral therapeutic agents
Chen, L., & Liang, J. (2020) · Materials Science and Engineering: C · doi:10.1016/j.msec.2020.110924 · Cited by 255
Jia, C., Chen, H., Wei, M., Chen, X., Zhang, Y., Cao, L., Yuan, P., Wang, F., Yang, G., & Ma, J. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s138400 · Cited by 106
Metadata
- Authors
- Bowman, M.-C., Ballard, T. E., Ackerson, C. J., Feldheim, D. L., Margolis, D. M., & Melander, C.
- Venue
- Journal of the American Chemical Society
- Publisher
- American Chemical Society (ACS)
- Published
- 2008-05-13
- Volume
- 130
- Issue
- 22
- Pages
- 6896-6897
- ISSN
- 0002-7863 (ISSN-L)
- 1520-5126
- OpenAlex
- W2050307916
- Cited by
- 371
- References
- 13
- FWCI
- 10.51
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.